Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Loteprednol Etabonate

02.16.21

Kala Pharmaceuticals Announces Eysuvis Now Covered by Express Scripts

Source: Kala Pharmaceuticals

02.12.21

Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%

Source: Akorn

01.07.21

Kala Pharmaceuticals Announces Commercial Availability of Eysuvis for the Treatment of Dry Eye Disease

Source: Kala Pharmaceuticals

11.16.20

Kala Pharmaceuticals Provides Update on Launch Plans for Eysuvis for the Treatment of Dry Eye Disease

Source: Kala Pharmaceuticals

10.27.20

Kala Pharmaceuticals Receives FDA Approval of Dry Eye Disease Treatment Eysuvis

Source: Kala Pharmaceuticals

05.26.20

Kala Pharmaceuticals Files New Drug Application to FDA for Eysuvis for Dry Eye Disease

Source: Kala Pharmaceuticals

05.04.20

Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye Disease

Source: Kala Pharmaceuticals

03.09.20

Kala Pharmaceuticals Announces Statistically Significant Results in STRIDE 3 Trial of Dry Eye Disease Drug Eysuvis

Source: Kala Pharmaceuticals

04.22.19

Akorn Receives FDA Approval for Generic Loteprednol Etabonate

Source: Akorn

04.02.19

Bausch + Lomb Announces US Launch of Lotemax SM

Source: Bausch + Lomb

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.